New Leaf Venture Partners, L.L.C. Cogent Biosciences, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $44.5 Million
- Q1 2025
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 250,765 shares of COGT stock, worth $2.85 Million. This represents 3.38% of its overall portfolio holdings.
Number of Shares
250,765
Previous 250,765
-0.0%
Holding current value
$2.85 Million
Previous $1.96 Million
23.17%
% of portfolio
3.38%
Previous 2.63%
Shares
3 transactions
Others Institutions Holding COGT
# of Institutions
195Shares Held
118MCall Options Held
62KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$103 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$102 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$101 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$82.8 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$79.1 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $747M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...